# ADA-Immunogenicity-ClinPharm-CDISC-FHIR-Interoperability-Framework  
*From ADA Assays to Standardized Regulatory Data Exchange*

![Regulatory-Interop Badge](https://img.shields.io/badge/Regulatory%20Interop-ClinPharm%20%7C%20BioA%20%7C%20FHIR-blueviolet)
![CDISC Badge](https://img.shields.io/badge/CDISC-ADaM%20Compliant-brightgreen)
![FHIR Badge](https://img.shields.io/badge/FHIR-R5-orange)
![License: Research](https://img.shields.io/badge/License-Research%20Use-yellow)

> **Goal:** Show how immunogenicity (ADA assay results) becomes *regulatory-grade data*
> supporting **PK interpretation**, **ADA risk assessment**, and **submission-ready formats**.

![Banner](banner.png)

---

## ğŸ”Œ Interoperability Pipeline

BioA ADA Measurement â†’ PK/PD Impact â†’ Regulatory-Readable Data
(Standard vs PandA)
â”‚
â–¼
ADA Standardization & Mapping via this Repo
â†’ CDISC ADaM-like dataset (ADIMMUN)
â†’ HL7 FHIR Immunogenicity Observations
â†’ PASS/ALERT Validation Summary

ğŸ‘‡ Example: ADA classification flowing into regulated data artifacts

---

## ğŸ“ Repository Structure

```plaintext
ADA-Immunogenicity-ClinPharm-CDISC-FHIR-Interoperability-Framework/
â”‚
â”œâ”€â”€ README.md
â”œâ”€â”€ config.yml                           # Points to upstream ADA-Panda-Mini reports/
â”‚
â”œâ”€â”€ notebooks/
â”‚   â”œâ”€â”€ 01_ingest_ada_from_panda_mini.ipynb
â”‚   â”œâ”€â”€ 02_build_adimmun.ipynb
â”‚   â”œâ”€â”€ 03_generate_fhir.ipynb
â”‚   â””â”€â”€ 04_validations.ipynb
â”‚
â”œâ”€â”€ intermediate/
â”‚   â””â”€â”€ ada_harmonized.csv               # Harmonized PK + ADA dataset
â”‚
â”œâ”€â”€ cdisc/
â”‚   â””â”€â”€ adam_like/
â”‚       â””â”€â”€ adimmun.csv                  # ADaM-like immunogenicity dataset
â”‚
â”œâ”€â”€ interoperability/
â”‚   â””â”€â”€ fhir_examples/
â”‚       â”œâ”€â”€ S001_ADA_Positive.json       # Example FHIR Observation resources
â”‚       â”œâ”€â”€ S002_ADA_Negative.json
â”‚       â””â”€â”€ (one per subject/visit)
â”‚
â”œâ”€â”€ validations/
â”‚   â””â”€â”€ summary.md                       # PASS/ALERT + data QC results
```

## âœ… Outputs (Auto-generated)

| Artifact | Format | Location | Purpose |
|---------|--------|----------|--------|
| ADA harmonized dataset | CSV | `intermediate/ada_harmonized.csv` | Standardized raw ADA + PK |
| **CDISC ADaM-like** | CSV | `cdisc/adam_like/adimmun.csv` | Regulatory PK/ADA analysis |
| **FHIR R5 Observations** | JSON | `interoperability/fhir_examples/*.json` | Clinical IT interoperability |
| **Validation Summary** | Markdown | `validations/summary.md` | PASS/ALERT compliance |

---

## ğŸ§¬ CDISC ADaM-like Example

```csv
USUBJID, VISIT, METHOD, PARAMCD, ADASTAT, CONC_WK52_NGM
S001, 52, Standard, ADAQUAL, NEG, 250.1
S001, 52, PandA, ADAQUAL, POS, 250.1
S010, 52, Standard, ADAQUAL, NEG, 200.4
S010, 52, PandA, ADAQUAL, NEG, 200.4
```
âœ… Distinguishes measured (Standard vs PandA)
âœ… PK exposure included
âœ… Ready for ER modeling / labeling decisions

## ğŸŒ FHIR (R5) Example
```json
{
  "resourceType": "Observation",
  "status": "final",
  "code": { "text": "Anti-drug antibody (ADA) assay" },
  "subject": { "reference": "Patient/S001" },
  "effectiveDateTime": "2025-01-01",
  "valueCodeableConcept": { "text": "ADA Positive" },
  "method": {
    "coding": [
      {
        "system": "https://example.org/bioanalytical-methods",
        "code": "PandA",
        "display": "PEG + Acid dissociation"
      }
    ]
  }
}
```
âœ… Carries method metadata required for traceability
âœ… Ready for EHR immunogenicity dashboards

---

### âœ… What This Enables

| Capability | Supported? |
|-----------|------------|
| Distinguish **Standard vs PandA** measurement | âœ… |
| Include PK exposure in ADA output | âœ… |
| Ready for **Exposureâ€“Response modeling** | âœ… |
| Retain **method traceability metadata** | âœ… |
| Compatible with **EHR SMART-on-FHIR** dashboards | âœ… |

---

## ğŸ“Œ Why This Matters (Business Case)

âœ… Links **bioanalytical performance** â†’ **true immunogenicity risk**  
âœ… Supports **dose adjustment & labeling** decisions  
âœ… Enables **machine-readable** ADA interpretation  
âœ… Aligned with **FDA/EMA immunogenicity guidance** & **CDISC ADaM IG**

> Immunogenicity isn't just a lab result â€” it drives clinical decision-making.

---

## ğŸ”— Related Repositories

| Repository | Description |
|-----------|-------------|
| ğŸ”¬ **bioanalytical-ADA-drug-interference-to-pandA-correction-method-development** | ADA drug masking + PandA correction simulation |
| ğŸ“„ **regulatory-clinpharm-ADA-immunogenicity-reporting-and-bioanalytical-summary** | BAR/ISI-style PK + immunogenicity report |
| ğŸ›ï¸ **this repo** | CDISC/FHIR regulatory interoperability |

---

## ğŸ“š References

- FDA (2019) â€” *Immunogenicity Testing of Therapeutic Protein Products*  
- Zoghbi et al., 2015 â€” PandA improves drug tolerance  
- CDISC ADaM IG â€” Immunogenicity metadata  
- HL7 FHIR â€” Observation: immunogenicity profiles  

---

## ğŸ§¾ Summary of Utility

âœ… Moves ADA from **assay tube â†’ clearance model â†’ regulatory decision**  
âœ… Reproducible & transparent  
âœ… CDISC & FHIR **interoperability-ready**  
âœ… **Recruiter-ready** regulatory data science portfolio ğŸ’¼  

---

## ğŸ› ï¸ Run
```bash
git clone https://github.com/camontefusco/ADA-Immunogenicity-ClinPharm-CDISC-FHIR-Interoperability-Framework
cd ADA-Immunogenicity-ClinPharm-CDISC-FHIR-Interoperability-Framework
pip install -r requirements.txt  # if included

# Run notebooks:
01_ingest_ada_from_panda_mini.ipynb
02_build_adimmun.ipynb
03_generate_fhir.ipynb
04_validations.ipynb
```
Update config.yml to point to upstream dataset in:
```bash
"you-repo for ada-panda"/reports/
````
---

## ğŸ“¬ Contact
Carlos Montefusco
ğŸ“§ cmontefusco@gmail.com
ğŸ”— GitHub: /camontefusco
